Hiroshima University: High Efficiency Cell Engineering Seminar

Webinars & Presentations Hiroshima University: High Efficiency Cell Engineering Seminar

Join us for a Seminar on High Efficiency Cell Engineering Seminar at Hiroshima University

Join us live from Hiroshima University for a Seminar on High Efficiency Cell Engineering

Tuesday, July 16, 2024
12:00 PM - 1:00 PM (JT)

In-person
Hiroshima University
Research Institute for Radiation Biology and Medicine
Fifth Floor Auditorium, Advanced Radiation Research Building
1-2-3 Kasumi, Minamiku, Hiroshima 734-8553, Japan

About the event

Join us for an exciting cell engineering lunch seminar on Tuesday, July 16th, from 12:00 pm (noon) - 1:00 pm at Hiroshima University!

Register to hear how guest speaker Dr. Steven Feldman, Stanford University's Site Head & the Scientific Director of the Laboratory of Cell & Gene Medicine leverages the MaxCyte platform to manufacture gene engineered products for patients. You will also gain valuable insights into how MaxCyte innovative electroporation platforms enable the efficient engineering of primary cells, stem cells, and many more cell lines.

Discover how our technology guarantees high cell viability and optimal recovery rates for a wide range of applications, including CRISPR, cell-based assays, cell therapy manufacturing, viral production, and so much more.

Space is limited so reserve your spot today by filling out the form!

Hosts

Steven Feldman, PhD

Site Head & Scientific Director, Laboratory for Cell & Gene Medicine, Stanford Center

Dr. Feldman is part of the Stanford Center for Cancer Cell Therapy and serves as the Site Head and Scientific Director of Stanford's GMP Facility. He has a leadership role and his team at Stanford focuses on the development and manufacture of novel cell therapies for the treatment of cancer.

Masahisa Ohishi, PhD

Senior Field Applications Scientist
MaxCyte, Inc.

Masa Ohishi is a MaxCyte Senior Field Applications Scientist based in Japan. Masa gained his PhD in retrovirus transduction at Osaka University in 2009, and worked at Kiko Tech, MaxCyte’s local distributor in Japan, as a researcher, FAS, and FAS Team Manager, where he gained 13 years of electroporation experience. He joined MaxCyte in October 2023 and supports customers and MaxCyte distributors across the APAC region.